BALANCE SHEET ACCOUNT DETAILS - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Balance Sheet Related Disclosures [Abstract] | ||
| Prescription Drug User Fee Act (PDUFA) fees | $ 221 | $ 442 |
| Clinical development activities | 318 | 0 |
| Drug product manufacturing subcontractor | 393 | 0 |
| Insurance | 275 | 766 |
| Deposits for meetings and conferences | 584 | 80 |
| Commercial data platforms | 454 | 364 |
| Patient assistance platforms | 0 | 75 |
| Financial reporting platforms | 106 | 98 |
| Deferred offering costs | 0 | 711 |
| Other | 491 | 419 |
| Total prepaid expenses and other current assets | $ 2,842 | $ 2,955 |
| X | ||||||||||
- Definition Commercial Data Platforms, Current No definition available.
|
| X | ||||||||||
- Definition Financial Reporting Platforms, Current No definition available.
|
| X | ||||||||||
- Definition Other Prepaid Expenses And Other Current Assets, Current No definition available.
|
| X | ||||||||||
- Definition Patient Assistance Platforms, Current No definition available.
|
| X | ||||||||||
- Definition Prepaid Clinical Development Activities, Current No definition available.
|
| X | ||||||||||
- Definition Prepaid Drug Product Manufacturing Subcontractor, Current No definition available.
|
| X | ||||||||||
- Definition Prepaid Prescription Drug User Fee Act Fees, Current No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|